Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors - Wikidata - awgldk - TriplyDB

Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors

Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors

http://www.wikidata.org/entity/Q28361214

about

Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration.Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors Activation and regulation of purinergic P2X receptor channels Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.Allosteric modulation of ATP-gated P2X receptor channels Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli.P2X7-mediated chemoprevention of epithelial cancers.Molecular Structure and Regulation of P2X Receptors With a Special Emphasis on the Role of P2X2 in the Auditory System.Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells.

P2860

Q24815912-5F5BA787-BFCF-4750-AA7B-CF12894E2BB1 Q34378750-5B6836B3-A1B8-4503-8EA3-70FAFB9A229B Q35122793-90C29E69-9733-44F1-9F84-E69D084FFED6 Q35214735-9BAE38A2-83A0-453E-B30E-3A0FBFDE31FC Q36825825-C6010E62-76AC-4391-8433-E35D8914FE91 Q37341915-7F9B17CC-E1D7-4004-941C-C1DBC51892C9 Q37618815-25F750B0-5C3D-4FCB-91A3-CD53D1457805 Q38655779-D1CDD5A7-E565-4743-8EBA-38157AEAEE9C Q45281019-0193828A-4E95-4BA4-9F33-C38C79C74FCD

P2860

Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors

http://www.wikidata.org/entity/Q28361214

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Serum constituents can affect ...... TP potency at P2X(7) receptors

@ast

Serum constituents can affect ...... TP potency at P2X(7) receptors

@en

Serum constituents can affect ...... TP potency at P2X(7) receptors

@nl

type

label

Serum constituents can affect ...... TP potency at P2X(7) receptors

@ast

Serum constituents can affect ...... TP potency at P2X(7) receptors

@en

Serum constituents can affect ...... TP potency at P2X(7) receptors

@nl

prefLabel

Serum constituents can affect ...... TP potency at P2X(7) receptors

@ast

Serum constituents can affect ...... TP potency at P2X(7) receptors

@en

Serum constituents can affect ...... TP potency at P2X(7) receptors

@nl

P1433

Q28361214-F47CE5E3-C25A-4805-92AC-E05A7FE8C638

P1476

Q28361214-C2BA154B-CB3F-4096-BBFD-B498E7229EA2

P2093

Q28361214-564971FF-FCBE-4868-B6B2-6654041B186B

Q28361214-6371551F-828B-40E7-972C-CF76728D1985

Q28361214-CC4FDEEB-8EE7-432B-8F26-4307A9172397

P2860

Q28361214-002B9958-C1BA-4A0D-A240-1BD3B61BE261

Q28361214-03D52A16-60DA-4DB1-96F5-7F29CB2BFDDE

Q28361214-0599A534-F835-4506-965D-F73A40C91166

Q28361214-111C0C0E-2439-4502-A05A-ED8A46645A3D

Q28361214-16C7DD30-BC7C-480D-B968-9A97E5F4149D

Q28361214-17412A66-7DBC-44A9-8B9E-00A9CE13B49E

Q28361214-1B137F32-16E2-4490-BCF4-F908E3ACAC5A

Q28361214-1C28E072-83B2-4632-82CE-DF3CE73F0D1D

Q28361214-1FBF26B2-BBE8-4DC7-B488-21C7869473A8

Q28361214-229BC2E9-8A27-4508-8BFB-75ACBFA2A3B5

P304

Q28361214-2BFA39E9-F1DC-46EB-B387-692E76F2853B

P31

Q28361214-FA660634-18A0-424B-ABB6-9525DEACE156

P356

Q28361214-A5837970-ECE7-46FF-A6BF-CC48B65DE572

P407

Q28361214-4BEFBD25-BF63-42B2-8B1B-AC61D9028EDD

P433

Q28361214-B159CEC1-9E24-43E0-8B5A-D2247E7BA263

P478

Q28361214-ACF72AA0-258D-4CFA-B52A-B14071F101EA

P577

Q28361214-CD36C698-C72E-4F79-B652-F608CFFD9CA4

P5875

Q28361214-2876E2F7-1A1C-497B-B069-E4AEFF889F0F

P698

Q28361214-CF67B715-BBE4-4F7A-86FF-D96B4E910573

P932

Q28361214-732A277B-4A11-46D7-B003-EF9D8AC13CAC

P356

P1433

British Journal of Pharmacology

P1476

Serum constituents can affect ...... TP potency at P2X(7) receptors

@en

P2093

A D Michel

http://www.w3.org/2001/XMLSchema#string

M Xing

http://www.w3.org/2001/XMLSchema#string

P P Humphrey

http://www.w3.org/2001/XMLSchema#string

P2860

The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA

Pharmacological characterization of the human P2Y11 receptor

Cloning and functional characterisation of the mouse P2X7 receptor

The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)

The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.

Modulation of ion channels by arachidonic acid.

Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.

Ionic effects on human recombinant P2X7 receptor function.

Covalent incorporation of 3'-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts.

Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line.

P304

1501-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0703968

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12069151

http://www.w3.org/2001/XMLSchema#string

P698

11264244

http://www.w3.org/2001/XMLSchema#string

P932

1572703

http://www.w3.org/2001/XMLSchema#string